{"transactions":[{"id":853536,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-09T20:08:18.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the total number of restricted stock units (\"RSUs\") will vest on March 15, 2027.  25% of the total number of RSUs will vest on each of March 15, 2028, March 15, 2029 and March 15, 2030, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"25% of the total number of restricted stock units (\"RSUs\") will vest on March 15, 2027.  25% of the total number of RSUs will vest on each of March 15, 2028, March 15, 2029 and March 15, 2030, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001665347-26-000006","document":"form4-03092026_080309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000166534726000006/form4-03092026_080309.xml","form_type":"4"}},{"id":920980,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T19:16:05.000Z","date":"2026-02-03","kind":"other","planned":false,"acquired":false,"shares":5753,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. (\"Purchaser\"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the \"Closing Amount\") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-036198","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665347/000119312526036198/ownership.xml","form_type":"4"}},{"id":920979,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T19:16:05.000Z","date":"2026-02-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":862500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. (\"Purchaser\"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the \"Closing Amount\") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. (\"Purchaser\"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the \"Closing Amount\") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration."}],"balance_after":5753,"source":{"system":"sec-edgar","filing":"0001193125-26-036198","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665347/000119312526036198/ownership.xml","form_type":"4"}},{"id":920978,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-03T19:16:05.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":312500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of compensatory Restricted Stock Units (\"RSUs\") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in full upon the earlier of (i) the consummation of a Change in Control (as defined in the Plan) or (ii) June 19, 2026, in each case, subject to the Reporting Person continuing to provide services through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings have been adjusted to correct an administrative error in prior Form 4s that resulted in the understatement of the total holdings."}],"balance_after":868253,"source":{"system":"sec-edgar","filing":"0001193125-26-036198","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665347/000119312526036198/ownership.xml","form_type":"4"}},{"id":1190574,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-26T20:25:29.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of compensatory Restricted Stock Units (\"RSUs\") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. One fourth (1/4th) of the compensatory RSUs shall vest on March 24, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory RSUs shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":550000,"source":{"system":"sec-edgar","filing":"0000950170-25-045617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665347/000095017025045617/ownership.xml","form_type":"4"}},{"id":1541759,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-04-15T17:30:25.000Z","date":"2024-04-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One fourth (1/4th) of the compensatory Restricted Stock Units shall vest on April 12, 2025, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0000950172-24-000190","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665347/000095017224000190/form4.xml","form_type":"4"}},{"id":3717511,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-27T16:55:41.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":939,"price":45.47,"value":42696.33,"ownership":{"direct":true},"balance_after":1595,"source":{"system":"sec-edgar","filing":"0000899243-18-031841","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318031841/doc4.xml","form_type":"4"}},{"id":3717510,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-12-27T16:53:39.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":2150,"price":76.36,"value":164174.0,"ownership":{"direct":true},"balance_after":19,"source":{"system":"sec-edgar","filing":"0000899243-18-031839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318031839/doc4.xml","form_type":"4"}},{"id":3821965,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-09-07T16:45:34.000Z","date":"2018-09-05","kind":"exercise","acquired":false,"shares":469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":4688,"derivative":{"underlying":"Common Stock","underlying_shares":469},"source":{"system":"sec-edgar","filing":"0000899243-18-024003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318024003/doc4.xml","form_type":"4"}},{"id":3821964,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-09-07T16:45:34.000Z","date":"2018-09-05","kind":"tax_withholding","acquired":false,"shares":239,"price":35.75,"value":8544.25,"ownership":{"direct":true},"balance_after":5349,"source":{"system":"sec-edgar","filing":"0000899243-18-024003","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318024003/doc4.xml","form_type":"4"}},{"id":3821963,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-09-07T16:45:34.000Z","date":"2018-09-05","kind":"exercise","acquired":true,"shares":469,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock."}],"balance_after":5588,"source":{"system":"sec-edgar","filing":"0000899243-18-024003","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318024003/doc4.xml","form_type":"4"}},{"id":3831567,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-08-28T19:51:49.000Z","date":"2018-08-27","kind":"exercise","acquired":false,"shares":869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":6950,"derivative":{"underlying":"Common Stock","underlying_shares":869},"source":{"system":"sec-edgar","filing":"0000899243-18-023428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318023428/doc4.xml","form_type":"4"}},{"id":3831566,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-08-28T19:51:49.000Z","date":"2018-08-27","kind":"tax_withholding","acquired":false,"shares":434,"price":35.15,"value":15255.1,"ownership":{"direct":true},"balance_after":5119,"source":{"system":"sec-edgar","filing":"0000899243-18-023428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318023428/doc4.xml","form_type":"4"}},{"id":3831565,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-08-28T19:51:49.000Z","date":"2018-08-27","kind":"exercise","acquired":true,"shares":869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock."}],"balance_after":5553,"source":{"system":"sec-edgar","filing":"0000899243-18-023428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318023428/doc4.xml","form_type":"4"}},{"id":3899935,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-06-08T17:32:45.000Z","date":"2018-06-06","kind":"exercise","acquired":false,"shares":468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F3","text":"On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":5157,"derivative":{"underlying":"Common Stock","underlying_shares":468},"source":{"system":"sec-edgar","filing":"0000899243-18-015794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318015794/doc4.xml","form_type":"4"}},{"id":3899934,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-08T17:32:45.000Z","date":"2018-06-06","kind":"tax_withholding","acquired":false,"shares":235,"price":47.7,"value":11209.5,"ownership":{"direct":true},"balance_after":4684,"source":{"system":"sec-edgar","filing":"0000899243-18-015794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318015794/doc4.xml","form_type":"4"}},{"id":3899933,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-08T17:32:45.000Z","date":"2018-06-06","kind":"exercise","acquired":true,"shares":468,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person filed a Form 4 on June 1, 2018, reporting the conversion of 869 Restricted Stock Units into shares of Common Stock. The amount of securities beneficially owned following this transaction contained a clerical error, and should have been 4,895. The amount of securities beneficially owned after taking into account the second transaction reported on June 1, 2018 remains correct."}],"balance_after":4919,"source":{"system":"sec-edgar","filing":"0000899243-18-015794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318015794/doc4.xml","form_type":"4"}},{"id":3910678,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-06-01T16:30:26.000Z","date":"2018-05-31","kind":"exercise","acquired":false,"shares":869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":7819,"derivative":{"underlying":"Common Stock","underlying_shares":869},"source":{"system":"sec-edgar","filing":"0000899243-18-014684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318014684/doc4.xml","form_type":"4"}},{"id":3910677,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-01T16:30:26.000Z","date":"2018-05-31","kind":"tax_withholding","acquired":false,"shares":444,"price":48.63,"value":21591.72,"ownership":{"direct":true},"balance_after":4451,"source":{"system":"sec-edgar","filing":"0000899243-18-014684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318014684/doc4.xml","form_type":"4"}},{"id":3910676,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-01T16:30:26.000Z","date":"2018-05-31","kind":"exercise","acquired":true,"shares":869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock."}],"balance_after":3958,"source":{"system":"sec-edgar","filing":"0000899243-18-014684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318014684/doc4.xml","form_type":"4"}},{"id":4003313,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-03-09T18:06:22.000Z","date":"2018-03-07","kind":"exercise","acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 27, 2017, the reporting person was granted 7,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":5625,"derivative":{"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0000899243-18-006988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318006988/doc4.xml","form_type":"4"}},{"id":4003312,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-09T18:06:22.000Z","date":"2018-03-07","kind":"tax_withholding","acquired":false,"shares":938,"price":58.43,"value":54807.34,"ownership":{"direct":true},"balance_after":4026,"source":{"system":"sec-edgar","filing":"0000899243-18-006988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318006988/doc4.xml","form_type":"4"}},{"id":4003311,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-09T18:06:22.000Z","date":"2018-03-07","kind":"exercise","acquired":true,"shares":1875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Common Stock."}],"balance_after":4964,"source":{"system":"sec-edgar","filing":"0000899243-18-006988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318006988/doc4.xml","form_type":"4"}},{"id":4019947,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-03-02T18:30:46.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest as to 25% of the units on March 1, 2019, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest as to 25% of the units on March 1, 2019, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":9000,"derivative":{"underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-18-006226","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318006226/doc4.xml","form_type":"4"}},{"id":4019946,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-02T18:30:46.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 25% of the shares on March 1, 2019, and the remainder shall vest in substantially equal installments over the 36 months immediately following such date."}],"balance_after":9000,"derivative":{"exercise_price":58.43,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-18-006226","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318006226/doc4.xml","form_type":"4"}},{"id":4019935,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-03-02T16:15:59.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":8688,"derivative":{"underlying":"Common Stock","underlying_shares":869},"source":{"system":"sec-edgar","filing":"0000899243-18-006100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318006100/doc4.xml","form_type":"4"}},{"id":4019934,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-02T16:15:59.000Z","date":"2018-03-01","kind":"tax_withholding","acquired":false,"shares":467,"price":55.51,"value":25923.17,"ownership":{"direct":true},"balance_after":3089,"source":{"system":"sec-edgar","filing":"0000899243-18-006100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318006100/doc4.xml","form_type":"4"}},{"id":4019933,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-02T16:15:59.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":869,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":3556,"source":{"system":"sec-edgar","filing":"0000899243-18-006100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318006100/doc4.xml","form_type":"4"}},{"id":4146047,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2017-12-01T16:45:36.000Z","date":"2017-11-29","kind":"exercise","acquired":false,"shares":868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":9557,"derivative":{"underlying":"Common Stock","underlying_shares":868},"source":{"system":"sec-edgar","filing":"0000899243-17-027812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924317027812/doc4.xml","form_type":"4"}},{"id":4146046,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-12-01T16:45:36.000Z","date":"2017-11-29","kind":"tax_withholding","acquired":false,"shares":331,"price":59.49,"value":19691.19,"ownership":{"direct":true},"balance_after":2687,"source":{"system":"sec-edgar","filing":"0000899243-17-027812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924317027812/doc4.xml","form_type":"4"}},{"id":4146045,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-12-01T16:45:36.000Z","date":"2017-11-29","kind":"exercise","acquired":true,"shares":868,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":3018,"source":{"system":"sec-edgar","filing":"0000899243-17-027812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924317027812/doc4.xml","form_type":"4"}},{"id":4219668,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-09-01T16:30:41.000Z","date":"2017-08-29","kind":"tax_withholding","acquired":false,"shares":1325,"price":72.14,"value":95585.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Amendment is being filed to correct the sale price and the number of shares sold to satisfy the tax withholding obligations in connection with the vesting and settlement of the Restricted Stock Units reported in the original Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Amendment is being filed to correct the sale price and the number of shares sold to satisfy the tax withholding obligations in connection with the vesting and settlement of the Restricted Stock Units reported in the original Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Amendment is being filed to correct the sale price and the number of shares sold to satisfy the tax withholding obligations in connection with the vesting and settlement of the Restricted Stock Units reported in the original Form 4."}],"balance_after":2150,"source":{"system":"sec-edgar","filing":"0000899243-17-021360","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924317021360/doc4a.xml","form_type":"4/A","original_submission_date":"2017-08-29"}},{"id":4222525,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2017-08-29T16:32:31.000Z","date":"2017-08-25","kind":"exercise","acquired":false,"shares":3475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 25, 2016, the reporting person was granted 13,900 Restricted Stock Units. 25% of such Restricted Stock Units vested on August 25, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":10425,"derivative":{"underlying":"Common Stock","underlying_shares":3475},"source":{"system":"sec-edgar","filing":"0000899243-17-021175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924317021175/doc4.xml","form_type":"4"}},{"id":4222524,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-08-29T16:32:31.000Z","date":"2017-08-25","kind":"tax_withholding","acquired":false,"shares":1306,"price":73.16,"value":95546.96,"ownership":{"direct":true},"balance_after":2169,"source":{"system":"sec-edgar","filing":"0000899243-17-021175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924317021175/doc4.xml","form_type":"4"}},{"id":4222523,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-08-29T16:32:31.000Z","date":"2017-08-25","kind":"exercise","acquired":true,"shares":3475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":3475,"source":{"system":"sec-edgar","filing":"0000899243-17-021175","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924317021175/doc4.xml","form_type":"4"}},{"id":4370303,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2017-03-28T18:49:08.000Z","date":"2017-03-27","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest as to 25% of the units on March 1, 2018, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest as to 25% of the units on March 1, 2018, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-17-008768","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924317008768/doc4.xml","form_type":"4"}},{"id":4370302,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":62015,"kind":"person","name":"Hooks Corwin Dale","position":1,"cik":"0001665347","reported_name":"Hooks Corwin Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-28T18:49:08.000Z","date":"2017-03-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 25% of the shares on March 1, 2018, and the remainder shall vest in substantially equal installments over the 36 months immediately following such date."}],"balance_after":15000,"derivative":{"exercise_price":68.31,"expiration_date":"2027-03-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-17-008768","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924317008768/doc4.xml","form_type":"4"}}]}